22 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 1
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x RNA TS TPMi x
BLKBLK proto-oncogene, Src family tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
NucleoplasmGroup enrichedappendix:22.0
lymph node:61.2
spleen:40.6
tonsil:51.4
BTLAB and T lymphocyte associatedCD markers
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedappendix:14.1
lymph node:29.3
spleen:14.6
tonsil:24.7
CCR7C-C motif chemokine receptor 7Cancer-related genes
CD markers
G-protein coupled receptors
Predicted membrane proteins
MitochondriaHead and neck cancer: 7.61e-7
Cervical cancer: 8.03e-6
Breast cancer: 3.84e-4
Testis cancer: 7.72e-4
Group enrichedappendix:88.8
lymph node:97.1
spleen:39.3
tonsil:77.2
CD19CD19 moleculeCD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Group enrichedappendix:37.4
lymph node:84.0
spleen:47.4
tonsil:68.3
CD72CD72 moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Mitochondria
Renal cancer: 2.49e-8
Group enrichedappendix:25.1
lymph node:71.1
spleen:64.7
tonsil:42.6
CD79ACD79a moleculeCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 1.18e-5
Renal cancer: 2.15e-5
Breast cancer: 8.45e-5
Group enrichedappendix:263.8
lymph node:515.1
spleen:317.9
tonsil:423.1
CD79BCD79b moleculeCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Nucleoplasm
Plasma membrane
Cytosol
Head and neck cancer: 2.35e-4
Group enrichedappendix:91.1
lymph node:311.5
spleen:157.4
tonsil:189.1
CLEC17AC-type lectin domain family 17 member APredicted membrane proteins
Group enrichedappendix:16.6
lymph node:30.4
spleen:19.2
tonsil:28.4
CNR2Cannabinoid receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Group enrichedappendix:3.1
lymph node:8.7
spleen:7.9
tonsil:6.9
CR2Complement C3d receptor 2CD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Breast cancer: 6.90e-4
Group enrichedappendix:68.3
lymph node:206.0
spleen:100.2
tonsil:153.8
CXCL13C-X-C motif chemokine ligand 13Cancer-related genes
Predicted secreted proteins
Renal cancer: 1.16e-10
Ovarian cancer: 5.41e-4
Endometrial cancer: 5.52e-4
Colorectal cancer: 9.12e-4
Group enrichedappendix:163.3
lymph node:599.9
spleen:423.8
tonsil:395.7
FCER2Fc fragment of IgE receptor IICancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedappendix:21.9
lymph node:47.4
spleen:52.6
tonsil:38.0
FCRL2Fc receptor like 2CD markers
Predicted membrane proteins
Group enrichedappendix:16.3
lymph node:28.4
spleen:25.9
tonsil:23.7
FCRL3Fc receptor like 3CD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Group enrichedappendix:18.1
lymph node:55.9
spleen:36.7
tonsil:32.3
FCRLAFc receptor like APredicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Group enrichedappendix:31.2
lymph node:80.5
spleen:56.4
tonsil:86.7
LTBLymphotoxin betaCancer-related genes
Plasma proteins
Predicted intracellular proteins
CentrosomeRenal cancer: 3.31e-7
Endometrial cancer: 2.36e-6
Head and neck cancer: 1.74e-4
Group enrichedappendix:18.6
lymph node:22.1
spleen:25.8
tonsil:10.1
MS4A1Membrane spanning 4-domains A1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneBreast cancer: 4.34e-5
Group enrichedappendix:240.0
lymph node:770.3
spleen:468.8
tonsil:789.8
P2RX5Purinergic receptor P2X 5Predicted intracellular proteins
Predicted membrane proteins
CytosolGroup enrichedappendix:40.9
lymph node:89.8
spleen:74.3
tonsil:47.1
SIT1Signaling threshold regulating transmembrane adaptor 1Predicted membrane proteins
Endometrial cancer: 1.94e-6
Renal cancer: 1.75e-5
Head and neck cancer: 1.14e-4
Cervical cancer: 6.56e-4
Melanoma: 8.17e-4
Group enrichedappendix:24.6
lymph node:56.1
spleen:21.9
tonsil:29.6
SP140SP140 nuclear body proteinPredicted intracellular proteins
Transcription factors
Nucleoli fibrillar center
Mitochondria
Group enrichedappendix:32.8
lymph node:64.4
spleen:38.3
tonsil:50.7
TLR10Toll like receptor 10CD markers
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedappendix:21.1
lymph node:51.7
spleen:34.7
tonsil:45.1
TNFRSF13CTNF receptor superfamily member 13CCD markers
Disease related genes
Predicted membrane proteins
NucleusCervical cancer: 4.44e-7
Group enrichedappendix:22.9
lymph node:46.1
spleen:43.5
tonsil:49.9
Page of 1